A new, easily ingested form of a compound that has already shown it can attack the roots of leukemia in laboratory studies is moving into human clinical trials, according to a new article by University of Rochester investigators in the journal, Blood.
Many Americans hospitalized for heart failure are coming up short when it comes to getting the therapy they need — especially women and minorities, say researchers at Duke University Medical Center.
Women who might have benefited from the use of an implantable heart monitor following a cardiac arrest were far less likely than men to have one prescribed, according to experts at the Duke University Medical Center.
Swedish researchers have discovered that oseltamivir (Tamiflu); an antiviral drug used to prevent and mitigate influenza infections is not removed or degraded during normal sewage treatment. Consequently, in countries where Tamiflu is used at a high frequency, there is a risk that its concentration in natural waters can reach levels where influenza viruses in nature will develop resistance to it.
Patients who undergo liver transplantation at age 60 or above have one-year and five-year survival rates similar to those of younger patients and they experience fewer episodes of rejection.
A summary of evidence on the diagnosis and treatment of low-back pain has prompted the American Pain Society (ASP) and the American College of Physicians (ACP) to issue a new treatment guideline. The guideline is based on a thorough analysis of published research conducted by investigators at the Oregon Evidence-Based Practice Center at Oregon Health & Science University.
The routine vaccination of children against Human Papilloma Virus (HPV) – the first adolescent vaccine against a sexually transmitted infection – will be discussed at the National Cancer Research Institute conference in Birmingham today (1515hrs, Tuesday 2 October).
New recommendations that restrict women who have previously been pregnant from donating platelets and plasma will have a major impact on the blood supply. The reason is a potentially deadly protein associated with Transfusion Related Acute Lung Injury, or TRALI.
A new, easily ingested form of a compound that has already shown it can attack the roots of leukemia in laboratory studies is moving into human clinical trials, according to a new article by University of Rochester investigators in the journal, Blood.
In response to a debate over whether all pregnant women should be screened for subclinical hypothyroid disease, The American College of Obstetricians and Gynecologists (ACOG) recommended against routine screening in a Committee Opinion in the October issue of Obstetrics & Gynecology.